WJCCR v1 1006

World Journal of Clinical Cancer Research www.directivepublications.org The effect of androgen deprivation therapy on the quantitative assessment of quality of life in New Zealand prostate cancer survivors Dosborne E and RacLeod R Corresponding author Dosborne E, Faculty of Health Sciences and Medicine, Bond Uni- versity, Robina, Queensland, Australia E-mail: [email protected] Received Date: December 29 2021 Accepted Date: December 31 2021 Published Date: January 27 2022 Abstract Men with glandular cancer expertise several challenges to their quality of life (QOL). whereas a number of these challenges mirror the direct effects of the cancer, further side-effects and symptoms are related to common treatments particularly steroid deprivation medical care (ADT). whereas many studies have examined the consequences of ADT on the QOL of men with glandular cancer, a lot of of this analysis is between 10-20 years previous and was conducted in North Ameri- ca or Europe. This study thus examined the consequences of ADT on QOL in glandular cancer patients (survivors) within the hemisphere. The registries of 2 New island based mostly hospitals were sourced to spot men with glandular cancer WHO were victimisation ADT for a minimum of six months (ADT cluster, n=205) and people WHO had ne’er used ADT (non-ADT cluster, n=143). Participants in each teams were mail-clad a letter of invite, the WHOQOL-BREF and 3 aspects of the WHOQOL-OLD QOL form. Response rates of forty first and four-hundredth were obtained for the ADT and non-ADT teams, sev- erally. QOL scores were usually similar between the teams, with the exception of physical QOL, that was considerably lower within the ADT cluster. Such results recommend that cancer clinicians, allied health professionals and cancer researchers shouldn’t simply consid- er the physical impact of ADT on their survivors’ risk of developing pathology, falls-related fracture and cardio-metabolic syndrome, how- ever conjointly devote time to make sure their survivors’ perception of their physical QOL isn’t compromised. Keywords cancer survivorship; cancer therapy; hormonal therapy; quality of life; prostate cancer Introduction Prostate cancer is that the most common kind of cancer for men in several countries together with New Zealand and Australia [1, 2]. As a results of high five year survival rates of half of one mile [2], 53,296 men area unit still alive five years post adenocarcinoma diagnosing in Australia. The high five year survival rates could mirror some com- bination of enhancements in early detection and treatment modalities together with surgical techniques, radiotherapy, therapy and ADT [3]. Of these treatments, ADT is maybe the foremost ordinarily prescribed, with ~50% of adenocarcinoma survivors seemingly to use ADT through- out their treatment [4, 5]. ADT reduces the and symptoms. Such effects embrace vital changes in body composition (increased fat mass and re- duced muscle and bone mass), reduced muscular strength, endurance, useful performance in activities of daily living and sexual operate still as exaggerated levels of fatigue and rates of different chronic conditions to- gether with pathology, falls-related fracture and metabolic syndrome [6, 8]. whereas men on ADT expertise bigger co-morbidity than their non- ADT peers, it’s not utterly clear however these ADT-related side-effects and symptoms have an effect on their QOL, with many studies reportage comparatively few vital variations in QOL between ADT and non-ADT adenocarcinoma survivors [9–11]. The relative lack of serious QOL variations, whereas maybe a surprise thanks to the side-effects and symptoms related to ADT could mirror many factors. the primary is that the literature includes studies that have compared adenocarcinoma survivors victimization ADT to adenocar- cinoma survivors undergoing radiotherapy and radical excision [9] or active police work [9–12]. As ADT, radiotherapy and radical excision all have renowned side-effects and symptoms [7, 13], an absence of the many vital variations within the QOL of men victimization these therapies is of very little surprise. Secondly, all of those studies were conducted in North America or Europe, with the North America studies involving knowledge from 1994 and 1995 [9, 10]. As ADT treatment protocols have modified significantly since that point and will conjointly dissent across countries [14, 16], newer studies in different non-North yankee and European countries is also required to raised quantify the modern impact of ADT on QOL in men with adenocarcinoma. Another issue with these studies could concern the QOL tools used, with the stud- ies typically victimization the SF-36 [9–11] though one study used the EORTC-C30 and sexual behaviour questionnaires (SBQ) [12]. whereas all of those QOL tools have adequate psychological science properties, the WHOQOL tools [17] have the intercalary advantage of providing wonderful society validity thanks to the means within which they were developed [18]. Scores on the WHOQOL tools, particularly those con- cerning physical and psychological QOL, area unit typically found to be moderately related with connected parts of the SF-36 [19], though the SF-36 seems to be way more seemingly to yield floor and ceiling effects [20]. The WHOQOL conjointly captures a awfully wide selection of rel- evant QOL problems, like social and environmental QOL, so extending QOL assessment on the far side factors that area unit restricted solely to direct issues concerning sickness and symptoms [19]. The subjective components that area unit assessed by the WHOQOL tools distinguish them from a lot of objective instruments, like the SF-36. This means, as an example, that the WHOQOL is in a position to differentiate between 2 adenocarcinoma survivors United Nations agency could expertise sim- ilar side- effects and symptoms, however United Nations agency could have terribly totally different perceptions on however these impairments have an effect on their QOL [18]. Therefore, the aim of this study was to use a cross- sectional style to look at the results of current ADT usage on glandular cancer survivors’ QOL as assessed by the WHOQOL. supported the glandular cancer QOL lit- erature and therefore the direct effects of ADT, it absolutely was hypoth- esised that the ADT cluster would exhibit reduced QOL across some do- mains, with the foremost probably distinction being for physical QOL. Short report Page - 01

World Journal of Clinical Cancer Research www.directivepublications.org things were reverse coded so a better score delineate elevated QOL, per the opposite sides. Statistical analyses All information analyses were conducted exploitation the program Sta- tistics Package for the Social Sciences (SPSS) v.19. In total, 0.01 of all responses were missing. Given the sample size, missing things on the WHOQOL-BREF were imputed by the mean score on the opposite things that the participant rated on an equivalent domain. to keep up the ordinal structure of the size, imputed scores were rounded. Missing things weren’t imputed once over 1/2 the things on the sub-scale were missing, during which case no sub-scale score was calculated for that respondent. Differences between the ADT and non-ADT teams in terms of the WHOQOL-BREF domains and also the 3 WHOQOL-OLD sides were tested employing a MANCOVA, dominant for age and time since di- agnosing. a major distinction in one in every of the domains was then followed up by an extra Associate in Nursingalysis that enclosed an ageand gender matched general population sample collected one year earlier [26]. This reference cluster was any divided into participants UN agency self-identified as unwell and well, so yielding a complete of 4 teams to be compared (non-ADT, ADT, general population Well, and general population Unwell). as a result of no WHOQOL-OLD scores were offered for the Unwell and Well teams, and there was no variable time since diagnosing for these teams, this comparison was created ex- ploitation Associate in Nursing ANCOVA, dominant for age, and fol- lowed up with post-hoc tests. to attenuate inflation of Type-1 error, the ANCOVA was solely conducted to explore variations within the WHO- QOL-BREF domain that yielded a major distinction within the on top of MANCOVA. The mean ages of the Well and Unwell teams were sixty five.2 years (SD=9.6) and 70.2 years (SD=10.1), severally. The minimum age was fifty one years for the Well, Unwell, and non- ADT teams, and fifty eight years for the ADT cluster. Results A description of the 2 cancer samples is given in Table 1. each teams were similar in quality and time since diagnosing, though the ADT cluster were considerably older and had a better prostate spe- cific substance (PSA) level. Discussion Due to the terribly high five year survival rates for variety of cancers as well as that of the prostate [2], a bigger quantity of analysis is current- ly specializing in the broader problems with cancer survivorshiprather than simply howto scale back mortality rates. a significant focus of this survivorship analysis is bothered with gaining Associate in Nursing in- sight into the impact of long usage of common treatments on numer- ous aspects of QOL and the way ancient and complementary therapies could offset these treatment-related problems. This study extends a number of the literature during this space because the mean length of ADT usage during this study of ~4 years was well bigger than the dura- tions of zero.5-2 years ADT cited antecedently. The main findings of this study were that the ADT and non-ADT teams had terribly similar QOL. Of the four WHOQOL-BREF domains (Psy- chological, Social and Environmental) and 3 WHOQOL-OLD sides (autonomy, social participation or death and dying), the sole important distinction was that the ADT cluster had considerably reduced physical QOL compared to the non-ADT and general population Well teams. Methods Design This study was a cross-sectional comparison of the QOL of glandular cancer survivors presently on ADT for a minimum of six months and people United Nations agency haven’t been on ADT. All people United Nations agency met these inclusions criteria were armoured a letter of invite, with no people with bone metastasis excluded. The inclusion of men with metastases was done as national written account informa- tion suggests that fifty of men on ADT square measure diagnosed with pathologic process cancer among eighteen months of beginning ADT [21] and 12-tone system of all glandular cancer survivors can have pathologic process sickness by two years post-diagnosis [22]. The re- sults rumored here compares the new information for glandular cancer survivors not victimization ADT (non-ADT group) to antecedently re- vealed information for those victimization ADT (ADT group) [23]. an equivalent information assortment procedures were used for the non- ADT cluster and therefore the antecedently revealed ADT cluster [23]. each elements of this study had approval from the port Regional Ethics Review Board (formerly called Northern Y Ethics Committee). Participants and procedures Non-ADT group: victimization the info of the North Shore Hospital in New island, all glandular cancer survivors United Nations agency weren’t presently, and haven’t been, on ADT were sent a letter invi- tatory them to participate within the gift study. Of the 143 survivors United Nations agency were known and sent asking letter, fifty seven in agreement to participate and came back a form, yielding a response rate of four-hundredth. The initial letter of invite enclosed a canopy letter that explained the study and the way they may participate. One week later, associateother letter was sent together with an info sheet, the WHOQOL-BREF and WHOQOL-OLD questionnaires and a sealed return-addressed envelope. In an effort to enhance the response rates [24], another letter package together with the WHOQOL-BREF and WHOQOL-OLD was sent 2-4 weeks later thanking those that had re- sponded and inspiring those that had not came back the questionnaires to try and do therefore. The mean age of this cluster was sixty seven.9 years (SD=8.7). ADT Group: Of the 205 survivors United Nations agency were known as being on ADT for extended than six months and sent asking letter to participate within the study, eighty four men came back the form, lead- ing to a response rate of forty first [23]. This cluster had a mean age of seventy eight.4 years (SD=8.2). Measures WHOQOL-BREF: The WHOQOL-BREF is that the transient version of the globe Health Organisation’s QOL instrument,with things contrib- utory to a score on the subsequent QOL domains: physical (7 items), psychological (6 items), social (3 items), and environmental (8 items). The WHOQOL- BREF has been valid to be used in older adults [25] and for the New island population [26]. WHOQOL-OLD: The WHOQOL-OLD is associate elective add-on module to alternative WHOQOL measures to assess sides of QOL that square measure pertinent to older adults [27]. the first scale contains six sides of 4 things every. However, to attenuate response burden, solely things that were judged by the researchers as being most relevant were enclosed. These were 3 of the six WHOQOL-OLD sides, specifically autonomy, social participation, and death and dying. solely 3 of the four things of the side death and dying were utilized in this study to min- imise participant burden. before applied mathematics analyses, these Short report Page - 02

World Journal of Clinical Cancer Research www.directivepublications.org The considerably reduced physical QOL for the ADT cluster was in keeping with older North yankee [11] and European [12] studies’ find- ings and certain reflects the numerous physical side-effects and symp- toms seen with prolonged ADT usage [6–8]. In distinction to the results for physical QOL, no important variations in alternative 3 QOL domains and 3 sides were determined between the ADT and every one alternative teams. whereas such a result’s in keep- ing with many alternative studies [9–11], it appeared well completely different to van Andel and Kurth [12] UN agency determined important reductions in many EORTC-C30 (emotional perform and international QOL) and SBQ domains (erectile pathology, sexual interest, sexual is- sues, sexual pleasure) QOL domains furthermore as increase in fatigue and hot flushes for the ADT cluster. However, the EORTC-C30 and a few domains of the SBQ could also be criticised as being a lot of of a proof listing than a real assessment of Associate in Nursing individual’s perceptions of their QOL [28]. so it’s quite doable that since the ADT cluster had been on ADT for a mean of roughly four years that they will became acquainted with these side-effects and symptoms, in order that they not perceived them as reducing their QOL, however that they were a daily a part of their lifestyle. Such a read is in keeping with Potosky et al. [29] UN agency determined that men with prostatic adenocarcino- ma UN agency were a pair of years post-radical cutting out or external beam radiation therapy had important variations in many symptoms however no important variations in QOL. conjointly, these results any support the rivalry of QOL researchers that assessing symptoms doesn’t essentially correlate to individuals’ perceptions of their QOL, particu- larly if such symptoms have existed for Associate in Nursing extended amount of your time. The significant loss of physical however no alternative QOL domains and sides within the ADT cluster counsel that cancer clinicians and al- lied health professionals ought to monitor and frequently devote a while to discussing problems moving physical QOL with their patients on ADT [30]. whereas sizable analysis has targeted on up chemo- radi- ation, surgical and medicine techniques to scale back side-effects and symptoms and/or maintain physical QOL in prostatic adenocarcinoma survivors on ADT [31, 32], cancer patients and survivors can also take pleasure in analysis examining complementary therapies specializing in increasing physical activity levels or up nutritionary intake. Physi- cal activity programs, particularly those involving resistance coaching show a lot of promise in up numerous domains of QOL furthermore as body composition and physical perform, thereby reducing the chance of pathology, falls connected fracture and cardio metabolic syndrome [33]. This study isn’t while not its limitations. Its sample size per cluster was moderate compared to the literature, being significantly larger than some studies [11, 12] however considerably but others [9, 10]. How- ever, as these larger studies concerned North yankee knowledge sets from 1994 and 1995, the relevancy of their results to however ADT is presently utilized in the hemisphere is somewhat unclear. This potential lack of relevancy of those older studies to this state of affairs within the hemisphere could replicate changes in ADT procedures over this era of your time, potential northern vs hemisphere distinction in treatment approaches further as variations in cultural attitudes between these countries. like alternative survey based mostly studies, the difficulty of however representative this sample of adenocarcinoma survivors area unit of the population is often some concern. However, the responses rates of ~40% within the current study were love alternative studies during this space [13, 34]. Further, as a cross-sectional comparison, it’s unattainable to work out causing, so these variations in QOL could are influenced by variations in these groups’ perceptions of their QOL before the cancer identification and/or treatment. in addition, the ADT and non-ADT weren’t matched in line with illness characteristics like prevalence of bone metastases, and comparisons so relied on applied mathematics management of covariates. Conclusion Overall, the results of this study recommend that cancer clinicians and allied health professionals ought to attempt to habitually monitor and discuss problems poignant the physical QOL of their adenocarcinoma patients on ADT further because the additional common outcomes to- gether with bone mineral density, prostate specific antigen levels and risk of cardio-metabolic syndrome. whereas the shortage of serious variations within the alternative QOL domains and sides was contrary to our hypothesis, it should replicate a mixture of many factors. These might probably include: (1) reduced side-effects of latest compared to historical ADT practices; (2) the boys on ADT had become acquainted with ADT’s side- effects and symptoms over many years and thus didn’t feel it affected several aspects of their QOL; or (3) the challenges of victimization quantitative questionnaires to assess QOL in clinical pop- ulations. Future analysis may need to use longitudinal analysis styles involving mixed-method knowledge assortment approaches to raised perceive the impact of ADT on QOL in adenocarcinoma survivors and to look at the impact of ancient oncologic and complementary therapies on up their physical QOL and reducing the danger of developing extra comorbidities. References 1. Ministry of Health (2010) Cancer: New registrations and deaths 2006. Ministry of Health, Wellington. 2. Australian Institute of Health and Welfare (2010) Cancer in Australia: an overview. 3. Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, et al. (2008) Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control 19:175–181. 4. Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS (2005) Increasing use of gonadotropin-releasing hormone ago- nists for the treatment of localized prostate carcinoma. Cancer 103:1615–1624. 5. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, et al. (2002) Contemporary patterns of androgen deprivation ther- apy use for newly diagnosed prostate cancer Urology 60:7–11. 6. Galvão DA, Taaffe DR, Spry N, Joseph D, Turner D, et al. (2009) Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross- sectional investigation. Prostate Cancer Prostatic Dis 12:198–203. 7. Gomella LG (2007) Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quali- ty- of-life issues. BJU Int 99:25–29. 8. Bylow K, Mohile SG, Stadler WM, Dale W (2007) Does andro- gen- deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review. Cancer Short report Page - 03

World Journal of Clinical Cancer Research www.directivepublications.org 110:2604– 2613. 9. Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, et al. (2003) General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21:1147–1154. 10. Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, et al. (2002 Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94:430–437. 11. Dacal K, Sereika SM, Greenspan SL (2006) Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc 54:85–90. 12. van Andel G, Kurth KH (2003) The impact of androgen depri- vation therapy on health related quality of life in asymptom- atic men with lymph node positive prostate cancer. Eur Urol 44:209–214. 13. Bestmann B, Loetters C, Diemer T, Weidner W, Küchler T, et al. (2007) Prostate-specific symptoms of prostate cancer in a Ger- man general population. Prostate Cancer Prostatic Dis 10:52– 59. 14. Organ M, Wood L, Wilke D, Skedgel C, Cheng T, et al. (2012) Intermittent LHRH Therapy in the Management of Castrate- re- sistant Prostate Cancer (CRPCa): Results of a Multi-institution- al Randomized Prospective Clinical Trial. Am J Clin Oncol doi: 10.1097/COC.0b013e31825d5664. 15. Al-Shamsi HO, Lau AN, Malik K, Alamri A, Ioannidis G, et al. (2012) The current practice of screening, prevention, and treat- ment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer. J Oncol doi: 10.1155/2012/958596. 16. Spry NA, Kristjanson L, Hooton B, Hayden L, Neerhut G, et al. (2006) Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer 42:1083–1092. 17. WHOQOL Group. (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403–1409. 18. Skevington SM (2002) Advancing cross-cultural research on quality of life: observations drawn from the WHOQOL devel- opment. World Health Organisation Quality of Life Assess- ment. Qual Life Res 11:135–144. 19. Bonomi AE, Patrick DL, Bushnell DM, Martin M (2000) Vali- dation of the United States’ version of the World Health Organi- zation Quality of Life (WHOQOL) instrument. J Clin Epidemi- ol 53:1–12. 20. Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD (2005) Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res 14:141–150. 21. Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA (2009) Predictors of clinical metastasis in prostate cancer pa- tients receiving androgen deprivation therapy: results from CaPSURE. Cancer 115:4470–4476. 22. Nørgaard M, Jensen AØ, Jacobsen JB, Cetin K, Fryzek JP, et al. (2010) Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol 184:162–167. 23. Keogh JWL, Shepherd D, Krägeloh CU, Ryan C, Masters J et al. (2010) Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing andro- gen-deprivation therapy. N Z Med J 123:20-29. 24. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, et al. (2002) Increasing response rates to postal questionnaires: sys- tematic review. BMJ 324:1183. 25. von Steinbüchel N, Lischetzke T, Gurny M, Eid M (2006) As- sessing quality of life in older people: psychometric properties of the WHOQOL-BREF. Eur J Ageing 3:116–122. 26. Krägeloh CU, Kersten P, Rex Billington D, Hsu PH, Shepherd D, et al. (2012) Validation of the WHOQOL-BREF quality of life questionnaire for general use in New Zealand: confirmatory factor analysis and Rasch analysis. Qual Life Res.doi: 10.1007/ s11136- 11012-0265-0269. 27. Peel NM, Bartlett HP, Marshall AL (2007) Measuring quality of life in older people: Reliability and validity of WHOQOL-OLD. Australas J Ageing 26:162–167. 28. Dahele M, Fearon KH (2006) Functional Parameters of Nutri- tion. In: Mantovani G, Anker S, Inui A, Morley J, Fanelli F et al., editors. Cachexia and Wasting: A Modern Approach. Milan: Springer pp 125–135. 29. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, et al. (2000) Health outcomes after prostatectomy or radiother- apy for prostate cancer: results from the Prostate Cancer Out- comes Study. J Natl Cancer Inst 92:1582–1592. 30. Keogh JW, Jones L (2011) The importance of promoting physi- cal activity for cancer survivorship. (invited editorial). N Z Med J 124:4–9. 31. Woodward EJ, Brown JE (2012) Denosumab in the treatment of bone metastases. Clin Invest 2:519–526.

32. Loriot Y, Massard C, Fizazi K (2012) Recent developments in treatments targeting castration-resistant prostate cancer bone metastases. Ann Oncol 23:1085–1094. 33. Keogh JW, MacLeod RD (2012) Body composition, physical fitness, functional performance, quality of life, and fatigue ben- efits of exercise for prostate cancer patients: a systematic re- view. J Pain Symptom Manage 43:96–110. 34. Munch TN, Strömgren AS, Pedersen L, Petersen MA, Hoer- mann L, et al. (2006) Multidimensional measurement of fa- tigue in advanced cancer patients in palliative care: an applica- tion of the multidimensional fatigue inventory. J Pain Symptom Manage 31:533–541. Short report Page - 04

This is an automatically generated text version. For the formatted version of record, download the PDF →